Overview

Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two simple and safe emergency department discharge therapy for Type 2 Diabetes patients with severe hyperglycemia and with no indications for inpatient admission.
Phase:
Phase 4
Details
Lead Sponsor:
John H. Stroger Hospital
Treatments:
Glipizide
Insulin
Insulin Glargine
Insulin, Globin Zinc